Johnson Johnson to Stop Sales of Vaginal Mesh Implants, Which are Focus of Lawsuits


In a letter to a federal judge in West Virginia, Johnson & Johnson’s Ethicon division stated it would stop selling four of its vaginal mesh implant models—also known as transvaginal mesh and bladder slings—which are the focus of multidistrict litigation against the company on behalf of more than 600 women, who say the defective medical devices caused internal injuries.

Johnson & Johnson also said that it requested approval from the Food and Drug Administration (FDA) to stop commercializing its vaginal mesh products. In March, the FDA said Johnson & Johnson sold its Gynecare Prolift vaginal mesh model for three years without adequate regulatory approval; this came just two months after the FDA ordered Johnson & Johnson and other manufacturers of vaginal mesh to study organ damage and other complications attributed to these potentially defective products.

Vaginal mesh implants are used to support internal organs in the treatment of stress-urinary incontinence and pelvic organ prolapse. However, the devices came under scrutiny regarding their safety after hundreds of women reported that the mesh eroded or shrank over time, causing pain and, in some cases, severe injuries.

Although Johnson & Johnson is discontinuing worldwide sales of four vaginal mesh products, the company said it is not recalling vaginal mesh devices already sold or surgically implanted.

If you were injured by vaginal mesh or another defective medical product, an experienced product liability attorney may be able to help you recover money for medical expenses and other damages.

Please contact for a free case evaluation and to locate a product liability attorney near you.